Quality of Life Evaluation in Patients with Follicular Cell Lymphoma: A Real-World Study in Europe and the United States.
P Connor Connor JohnsonAbigail Lucy BaileyQiufei MaNeil MilloyEmilia BiondiRuben G W QuekSarah WeatherbySophie BarlowPublished in: Advances in therapy (2024)
Patients with FL at later LOTs had significantly worse scores in most QoL aspects than earlier LOTs. European patients had significantly lower functioning and higher symptom burden than in the US. These real-world findings highlight the need for novel FL therapies that alleviate patient burden, positively impacting QoL.